The following elements will have their visibility changed, please review the list before confirming the visibility change

Study

Study Name: Trypanosoma vivax Lins genome sequencing

Projects

Biosamples

Organisms

Biosamples: 0 Seq. Projects: 1
STUDY INFORMATION
GOLD Study ID Gs0156686
Study Name Trypanosoma vivax Lins genome sequencing
Other Names
NCBI Umbrella Bioproject Name
NCBI Umbrella Bioproject Accession
SRA Studies
Legacy ER Study ID
Legacy GOLD ID
Added By JGI automated process on 2022-03-02
Last Modified By
PI
Description Single-celled parasitic protists from the Kinetoplastida order are the etiological agents of trypanosomiasis, an important neglected disease that affects humans, domestic and wild animals world-wide. Animal tripanosomiasis, also known as Nagana, are caused by different species being Trypanosoma vivax the most prevalent in livestocks in West Africa. T. vivax is disseminated across Africa and South America, infecting diverse mammals like cattle, sheep, calves and goats leading to a profound economical impact. T. vivax strains are difficult to maintain under laboratory conditions and this new genome will contribute for further comparative studies. The sample was originally isolated from Bos taurus and replicated in Capra hircus for experimentation
Relevance
Study Information Visibility Public
Metagenomic Study No
Publication
Is GEBA
Is HMP
ECOSYSTEM CLASSIFICATION
Ecosystem
Ecosystem Category
Ecosystem Type
Ecosystem Subtype
Specific Ecosystem
Ecosystem Path ID 1
STUDY COMPOSITION
Number of Biosamples 0
Number of Organisms 1
Number of Seq Projects 1
Number of Analysis Projects 1
Number of Related Studies 0

 

 

  You are going to add the following user to ALL Sequencing Projects, Biosamples and Analysis Projects that
sit under this study (a cascading permission update).

 

Contact Name/Email:

Do you want to continue?

 

 

  You are going to remove permissions for the following user to all Sequencing Projects,
Biosamples and Analysis Projects under this study.

 

Contact Name/Email:

Do you want to continue?